Applied Graphene Materials PLC Result of AGM (8865K)

TIDMAGM

RNS Number : 8865K

Applied Graphene Materials PLC

18 December 2018

18 December 2018

Applied Graphene Materials plc

("Applied Graphene Materials", "the Group" or "the Company")

Result of Annual General Meeting

Applied Graphene Materials, the producer of specialty graphene materials, announces that, at its Annual General Meeting held on 18 December, all resolutions put to shareholders were duly passed.

For further information, please contact:

Applied Graphene Materials [phone]

Adrian Potts, Chief Executive Officer

David Blain, Chief Financial Officer

N+1 Singer [phone]

Richard Lindley / Justin McKeegan

Hudson Sandler [phone]

Charlie Jack / Emily Dillon

Notes to Editors

Applied Graphene Materials works in partnership with its customers, using its knowledge and expertise to provide bespoke graphene dispersions and formats to deliver enhancements and benefits for a wide range of applications. The Group's strategy is to target commercial applications in three core markets: coatings, composites and functional materials.

The Group has developed proprietary bottom-up processes which are capable of producing high purity graphene nanoplatelets using a continuous process. The manufacturing process is based on sustainable, readily available raw materials and therefore does not rely on the supply of graphite, unlike a number of other graphene production techniques. Applied Graphene Materials owns the intellectual property and know-how behind this process.

Applied Graphene Materials was founded by Professor Karl Coleman in 2010 with its operations and processes based on technology that he initially developed at Durham University. The Group was admitted to AIM in November 2013, raising GBP11 million, and is based at the Wilton Site on Teesside. In January 2016, the Group raised GBP8.5m to support its ongoing activities and in October 2017 the Group raised a further GBP9.8m.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

RAGEAKAPFANPFFF

(END) Dow Jones Newswires

December 18, 2018 11:33 ET (16:33 GMT)